March 2017 FDA Recall Drug by Legacy Pharmaceutical Packaging Llc
D-0606-2017 - Presence of Foreign Tablets/Capsules

This Class II drug recall was voluntarily initiated by Legacy Pharmaceutical Packaging Llc on March 7, 2017 for the product Drug. The FDA reported the reason for recall as presence of foreign tablets/capsules. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0606-2017

Reason for Recall
Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.
Initiated
03-07-2017
Reported
03-29-2017
Quantity
48,012 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Legacy Pharmaceutical Packaging LLC
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Product was shipped to distribution centers in TN, IN, and AZ then further shipped the product to retail pharmacies nationwide in the USA.
ATENOLOL Tablets, USP, 50 mg, 30-count bottle, Rx only, Distributed by: The Kroger Co., 1014 Vine Street, Cincinnati, OH 45202; Manufactured for: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534; Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045; NDC 68645-493-54.

Batch or Lot Expiration Information

Lot# 161901, Exp 04/18